. Preparation of the test solution.
5. Analysis of cell viability by MTT. 6 . Cell treatment and imaging exogenous H2S.
7. C. elegans treatment and imaging endogenous H2S. 8 . Limit of detection 9. Data availability. 10 . Table S1 Crystal data and structure refinement. 14. Figure S5 18. Figure S27 -S28 HRMS spectra of products collected by a Xevo G2-XS QTof spectrometer.
19. Figure S29 MS spectra of PTZ-P4 by Microflex LT MALDI-TOF system. NMR spectra detection were recorded by a Bruker AV-400 instrument (Bruker, Germany) and reported in ppm downfield. High resolution mass spectra (HRMS) were obtained by a Xevo G2-XS QTof spectrometer (Waters, UK). All tested compounds were determined through a reverse phase C18 column by peak area integration (Agilent HPLC 1260, USA). Mass spectra were also collected by MALDI-TOF system (Microflex LT, Bruker, Germany). UV/Vis absorption and fluorescence spectroscopy were determined by UV spectrophotometer (UV-1800, Shimadzu, Japan) and fluorescence spectrophotometer (FluoroMax-4, Horiba, Japan). Cell and C. elegans imaging experiments were evaluated with fluorescence microscope (Carl Zeiss, Germany).
Synthesis
Scheme S1 Synthetic route of BODIPY-CHO.
Synthesis of compound 1. As described in Scheme S1, protection of aldehyde group was consulted with previous study. 1 A mixture of benzene-1,4-dicarbaldehyde (1.34 g, 10 mmol), ethylene glycol (0.75 g, 12 mmol) dissolved in toluene (40 mL), catalytic quantity of p-toluene sulfonic acid was added and the solution was refluxed for 10 h. After that, the solvent was removed under reduce pressure to get the crude product, and purified by silica gel column (dichloromethane/nhexane=10:1) to obtain compound 1 in 74.36% as yield. 
Compound 2 (1 mmol, 0.45 g) was dissolved in tetrahydrofuran (50 ml) containing 5% HCl. Then the mixture was stirred at room temperature for almost 8 h. After the reaction completed, NaOH 1 N solution was added until pH was around 7. The mixture was extracted with dichloromethane and solvent was removed. The residue was purified by silica gel column (dichloromethane/n-hexane=3:1) to get BODIPY-CHO (yield 90% 3. Proposed mechanism of PTZ-P1 by reacting with H2S.
PTZ-P1 (0.5 mmol, 0.19 g) was dissolved in 10 mL DMSO and added dropwise with NaHS (0.5 mmol, 0.028 g) dissolved in 10 mL distilled water. Then the mixture was stirred for 4 h at room temperature. After reaction completed, distilled water was added and extracted with ethyl acetate.
The organic layer was separated and dried with Na2SO4. After concentrating in vacuo, the crude product was purified by silica gel column (dichloromethane/ethyl acetate=10:1) to get PTZCNSF 
Preparation of the test solution.
Sodium hydrosulfide (NaHS) was dissolved in distilled water to 10 mM. A stock solution (1 mM) of PTZ-P1, PTZ-P2, PTZ-P3 and PTZ-P4 were both prepared in DMSO. Take PTZ-P1 for example, test solutions of PTZ-P1 were diluted to 2 mL with a mixture of distilled water and DMSO
(1:1, V/V), while small aliquots of NaHS solution was added for detecting UV-vis absorption and fluorescence property.
The solutions of various analytes were prepared from H2O2, HClO, NaCl, KCl, CaCl2, NaHSO3, Na2S2O3, Na2SO3, Na2SO4, K3PO4, Phenylalanine, Arginine, Glutamic, Cysteine and Glutathione respectively. Small aliquots of each testing species solution were added. The resulting solution was shaken well and incubated for 10 min at room temperature before recording the fluorescent spectra.
Analysis of Cell Viability by MTT.
HeLa cells were cultured in complete 1640 medium, containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin at 37 °C in atmosphere containing 5% CO2. After 90% confluence, the cells were cultured into 96-well plates (5000 cells/well, 100 μL). Cells were treated with different concentrations of PTZ-P4 (80, 70, 60, 50, 40, 30, 20, 10 μM) for 24 h. Then, MTT stock solution (5.0 mg/mL, 100 μL) was added to each well for incubating 4 h to form purple crystal formazan. At the end of incubation, DMSO (100 μL) was added for 10 min microvibration after removing medium.
The absorbance was measured at 570 nm on a microplate reader (Thermo, USA).
6. Cell treatment and imaging exogenous H2S.
After 90% confluence, cells were seeded in confocal culture dishes for 24 h. Aqueous NaHS was used as exogenous H2S source. Cells were preincubated with 20 μM PTZ-P4 for 5 h. Subsequently, cells were washed with PBS (pH=7.4) for three times and incubated with H2S (100 μM) for 3 h. were exposed to anesthesia and images were collected by fluorescence and confocal microscopes.
Limit of detection
It is reported that variable estimates of physiological relevant H2S ranging from nano-to millimolar levels, but the exact H2S concentrations remain controversial. [8] [9] [10] [11] [12] According to previous study with Equation (1), 13 we calculated the limit of detection of PTZ-P4 to H2S, which was 4 μM satisfying well with this range.
Equation (1): CL=kSbi/m
Where, m is the slope of the linear regression equation shown in Figure S1 . Sbi is the standard deviation of the blank measures. Generally, k=3, P < 0.01, so we obtained CL = 4 μM. Figure S18 
